Open Access TC-PTP is a ubiquitous non-receptor type protein tyrosine phosphatase that shows highest expression in hematopoietic tissues. It regulates many signal transduction pathways in hematopoietic as well as non-hematopoietic cells. TCPTP has two splice variants, an endoplasmic reticulum-localized TC48, and predominantly nuclear TC45. Upon various stress conditions and insulin stimuli, TC45 comes out of the nucleus and shuttles between the nucleus and the cytoplasm. TC48 also traffics from the ER to the ERGIC and Golgi and back to the ER. Many receptor tyrosine kinases such as EGF receptor, insulin receptor and Met-receptor are substrates of both the TC-PTP isoforms. TC48 and TC45 have unique interacting partners and substrates as well.
PROTEIN FUNCTION
T-cell protein tyrosine phosphatase (TCPTP) is one of the earliest discovered tyrosine phosphatase belonging to the protein tyrosine phosphatase (PTP) super family of enzymes (Cool et al. 1989) . TCPTP is a classical Class I cysteine-based non-receptor type 2 tyrosine phosphatase, which was first cloned from a T-cell c-DNA library. In human cells, TCPTP is encoded by the PTPN2 gene and there are two major isoforms of TCPTP, TC48 and TC45 that localize to the endoplasmic reticulum (ER) and the nucleus, respectively (Lorenzen et al. 1995) . TC45 has a well established role in several signaling pathways such as the insulin signaling, TNF-α signaling, integrin signaling, inflammation and immune response (Dubé and Tremblay 2005; Fukushima et al. 2010; van Vliet et al. 2005; Mattila et al. 2005; Doody et al. 2009) including several substrates at the plasma membrane, cytoplasm and the nucleus. However, the role of TC48 isoform is not understood clearly as only few substrates of TC48 have been identified, and its role in the ER and Golgi is yet to be uncovered (Muppirala et al. 2013 ).
PTPN2 gene is also associated with chronic inflammatory diseases such as Type-I diabetes and Crohn's disease, ulcerative colitis and rheumatoid arthritis (Burton et al. 2007; Franke et al. 2008; Moore et al. 2009; Festen et al. 2011) .
Most of the studies on TCPTP have been done using the substrate-trappping mutant, RNAi against TCPTP and Ptpn2 -/-(TCPTP gene) knockout fibroblasts. In vivo studies using Ptpn2 -/-mice were not possible, as the knockout mice die within 3 weeks. Recent studies using Ptpn2 +/-hepatocytes from heterozygous mice showed the role of TCPTP in glucose homeostasis (Fukushima et al. 2010) and from TCPTP knockout neuronal cells TCPTP was found to be a negative regulator of hypothalamic leptin signaling contributing towards the development of cellular leptin resistance in obesity (Loh et al. 2011) . Knockdown of TCPTP impaired autophagosome formation and cytokine-induced expression of autophagy related genes and increased apoptosis in human intestinal epithelial cells . Thus, a new role of TCPTP has emerged in the field of autophagy. TCPTP is also known to regulate ER-stress (Bettaieb et al. 2011) . TCPTP knockout MEFs show hyperphosphoryaltion and delayed degradation of PDGFR accompanied by increased recycling of PDGFR to the cell surface. This suggested the role of TCPTP in endocytic trafficking (Karlsson et al. 2006) . However, it is not known as to which isoform of TCPTP has a major role in this pathway.
TCPTP seems to regulate many pathways in cells, some of which are yet to be deciphered. The individual roles of TC45 and TC48 isoforms are also to be delineated.
REGULATION OF ACTIVITY
TCPTP is known to be regulated by several mechanisms. Transcriptionally, mRNA levels of TCPTP have been shown to fluctuate throughout the cell cycle (Tillmann et al. 1994) . A domain responsible for transcriptional repression during Sphase has been identified to a region between 492 and 1976 bp upstream of the transcription initiation site in TCPTP gene (Wee et al. 1999) . TC45 and TC48 mRNA levels increase in G1 phase during liver regeneration (Kamatkar et al., 1996) . Posttranscriptional regulation of rat TCPTP mRNA was seen during mitogenic stimulation of T-lymphocytes (Rajendrakumar et al. 1993) . TCPTP undergoes post-translational modification via serine phosphorylation. Rat TC45/PTP-S2 has been shown to be phosphorylated during mitosis and this phosphorylation retarded its electrophoretic mobility (Nambirajan et al. 2000) . It has also been shown that Ser-304 is the major site of phosphorylation in human TC45 and this phosphorylation was mediated by CDKs during mitosis (Bukczynska et al. 2004 ). TC48 (endogenous or overexpressed) did not get phosphorylated at Ser-304, which suggested the specificity of this phosphorylation to TC45.Though this Ser-304 phosphorylation did not change the activity, protein stability or localization of TC45, it might contribute towards higher substrate specificity in vivo (Bukczynska et al. 2004) . Recent work has also discovered another level of control of PTPN2 expression by reactive oxygen species-responsive miR-210 that regulates proliferation and migration of adipose-derived stem cells via PTPN2 downregulation (Kim et al. 2013) .
INTERACTIONS
TC45 interacts with several proteins which are also its substrates: a) receptor tyrosine kinases such as insulin receptor (IR) (Walchli et al. 2000; Galic et al. 2003) , epidermal growth factor receptor (EGFR) (Tiganis et al. 1998) , colonystimulating factor-1 receptor (CSFR) (Simoncic et al. 2006) vascular endothelial growth factor receptor (VEGFR) (Mattila et al. 2008) and Met-receptor tyrosine kinase (Sangwan et al. 2008) b) nuclear proteins such as STAT1, STAT3, STAT5 and STAT6 (Aoki and Matsuda, 2002; ten Hoeve et al. 2002; Yamamoto et al. 2002; Lu et al. 2007) c) cytoplasmic proteins such as JAK1 and 3 (Simoncic et al. 2002) , p52Shc (Tiganis et al. 1998) , Src tyrosine kinases (van Vliet et al. 2005) , and Caveolin-1 (Borza et al. 2010) .
TC48 has been shown to dephosphorylate the receptor tyrosine kinases -EGFR (Tiganis et al. 1998 ), IR (Galic et al. 2003 and Met-receptor tyrosine kinase (Sangwan et al. 2008 ) in the endoplasmic reticulum, which are dephosphorylated by TC45 at the plasma membrane. Till recently, unique substrates for TC48 had not been identified. The only unique substrates of TC48 which have been identified are C3G (Mitra et al. 2011) , syntaxin 17 (Muppirala et al. 2012 ) and BCR-Abl (Mitra et al. 2013 ). C3G and BCR-Abl also interact with TC45 but are not dephosphorylated by TC45.
Other proteins which have been identified as interacting partners of TC48 are p23 and p25, two members of the p24 cargo receptor family (Gupta and Swarup 2006) , GCP60, reticulon 3 and VAP-33 which belong to the early secretory pathway (Muppirala et al. 2013) . PECAM-1, GPNMB, CRELD1 and JAM-2, which are proteins involved in cell adhesion, have also been identified as TC48-interacting proteins by yeast two-hybrid assay (Muppirala et al. 2013) .
PHENOTYPES

Loss of TCPTP is not embryonic lethal but TCPTP
-/-mice die within 3-5 weeks of age (Heinonen et al. 2004) . TCPTP -/-mice suffered from severe anemia, splenomegaly, lymphadenopathy, and thymic atropy by 3 weeks of age (You-Ten et al. 1997) . These animals showed altered numbers of B and T cells and the splenocytes had impaired responses to lipopolysaccharide (LPS -B cell mitogen) and concanavalin A (ConA -T cell mitogen). Hence, these mice were not only defective in B and T cell production but also showed impaired B and T cell functions (Heinonen et al. 2004; Doody et al. 2009 ).
TCPTP
-/-mice showed symptoms of runting, hunched posture, diarrhea, and weight loss. Further investigation into role of early lethality in TCPTP -/-mice showed that they develop progressive systemic inflammatory disease. Deletion of TCPTP resulted in overproduction of cytokines (IFN-γ, TNF-α, and nitric oxide) after 3 days of birth. It was proposed that in absence of TCPTP, JAK and STAT activated by IFN-γ would not be dephosphorylated, leading to elevated expression levels of TNF-α and iNOS ultimately leading to systemic inflammatory disease (Simoncic et al. 2002; Doody et al. 2009 ).
Drosophila orthologue of human TCPTP/PTP1B, PTP61F has been shown to help maintain growth, life span and fecundity, reiterating the importance of TCPTP in regulating cell survival signaling pathways.
MAJOR SITES OF EXPRESSION
Both the TCPTP isoforms are expressed ubiquitously in embryonic and adult tissues, with highest expression found in hematopoietic tissues (Lorenzen et al. 1995) . TCPTP functions in regulating various signal transduction pathways in hematopoietic as well as non-hematopoietic cells.
SPLICE VARIANTS
Four alternate splice variants of TCPTP were identified in rat cells -PTP-S1, PTP-S2, PTP-S3, and PTP-S4, of which PTP-S2 and PTP-S4 were the major forms (Reddy and Swarup 1995) . In human, only two splice variants are found -TC45 (PTP-S2 homolog) and TC48 {PTP-S4 homolog (Cool et al. 1989; Champion-Arnaud et al. 1991) . These two splice variants of TCPTP, TC48 and TC45, differ in their sub-cellular localizations and functions. TC48, a longer isoform of 48kDa molecular weight shows ER localization (Lorenzen et al. 1995) , whereas, TC45, a smaller isoform of 45kDa, is mostly nuclear (Radha et al. 1994; Tillmann et al. 1994; Lorenzen et al. 1995; Reddy and Swarup 1995; Kamatkar et al. 1996) . Both the isoforms have a bipartite nuclear localization signal (NLS) (Lorenzen et al. 1995; Tillmann et al. 1994) . TC45 is generated by a unique exon at the 3' terminus of the TCPTP gene, which codes for 6 hydrophilic amino acids. TC48 is generated by a splicing event, which replaces C-terminal 6 amino acids of TC45 with 34 amino acids (mostly hydrophobic) in TC48. This hydrophobic tail masks the NLS in TC48 isoform, due to which TC48 does not localize to the nucleus. When the hydrophobic tail of TC48 is deleted, TC48 shows nuclear localization (Lorenzen et al. 1995) .
REGULATION OF CONCENTRATION
null
ANTIBODIES
There is no specific antibody available that recognizes TC48 or TC45 isoform differentially. This is compounded by the fact that TC48 isoform protein levels are lower than the TC45 isoform. A variety of commercial vendors have antibodies available against TC-PTP molecules which recognize both the isoforms. Anti TC-PTP (6F3) and (3E2) antibodies from MEDIMABS, CANADA and anti-human/mouse/rat TC-PTP antibodies from R&D systems, USA have been used widely in the literature. Our laboratory has raised a mouse monoclonal antibody G11 which recognizes rat TC45, TC48, overexpressed human TC45 and TC48 proteins. Sangwan V et al. 2008 This molecule exists in 9 states , has 8 transitions between these states and has 0 enzyme functions.(Please zoom in the pdf file to view details.)
